STOCK TITAN

Outset Medical, Inc. - OM STOCK NEWS

Welcome to our dedicated page for Outset Medical news (Ticker: OM), a resource for investors and traders seeking the latest updates and insights on Outset Medical stock.

Outset Medical, Inc. (symbol: OM) is a pioneering medical technology company committed to revolutionizing the dialysis experience. The company’s primary product, Tablo, is an innovative dialysis machine designed to simplify and streamline the process of Renal Replacement Therapy. By focusing on a patient-centric approach, Outset Medical places patient care, ease of use, and cost-efficiency at the forefront of its operations.

The Tablo dialysis system is built with a user-friendly touchscreen display that offers step-by-step visual and conversational instructions, making it accessible to both patients and caregivers, regardless of their experience level. This intuitive design dramatically reduces the complexity and cost associated with traditional dialysis treatments. Tablo can be used across various settings, including hospitals, chronic care dialysis clinics, and at home, making it a versatile solution for renal care.

Outset Medical’s mission is to improve the care experience for patients, families, providers, and physicians, while also enhancing cost-efficiencies for healthcare providers. The company achieves this by combining expertise from different healthcare fields, fostering an environment of cross-disciplinary innovation. This approach has led to significant advancements in dialysis technology and patient care.

Recent achievements include regulatory approvals and partnerships aimed at expanding Tablo’s reach and improving its functionalities. Financially, Outset Medical has shown robust growth, supported by a dedicated team of professionals and continuous innovation in their product offerings. The company's efforts are geared towards giving people their time back by reducing the dialysis process's complexity and duration.

Stay updated with the latest developments and news about Outset Medical, Inc. to learn how this industry leader is transforming renal care.

Rhea-AI Summary
Outset Medical, Inc. (OM) announces participation in Stifel 2023 Healthcare Conference and Jefferies London Healthcare Conference. Management to engage in fireside chats at the events. Live and archived webcasts available on the Outset website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.66%
Tags
conferences
-
Rhea-AI Summary
Outset Medical, Inc. (OM) Reiterates 2023 Revenue Guidance of $130 Million, Reports Q3 2023 Revenue of $30.4 Million, and Gross Margin of 23.6%. Net Loss Was ($46.2) Million, Non-GAAP Net Loss of ($35.3) Million. Operating Expenses Were $52.6 Million. Outset reiterated its 2023 revenue guidance of approximately $130 million and its previous gross margin guidance for the year to be in the low-20% range, exiting the fourth quarter in the mid-20% range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.39%
Tags
-
Rhea-AI Summary
Outset Medical, Inc. announces significant data findings on the use of Tablo Hemodialysis System, including increased racial diversity among users, enhanced patient outcomes in the Medicare fee-for-service population, and decreased hospital transfers in rural Alaskan communities. The findings will be presented at the American Society of Nephrology's Kidney Week 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.21%
Tags
none
Rhea-AI Summary
Outset Medical, Inc. (Nasdaq: OM) will release its financial results for Q3 2023 on November 7, 2023, after the close of trading. Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO, will host a conference call at 2:00 pm Pacific Time to discuss the results. Interested participants can register online to listen to the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.31%
Tags
conferences earnings
-
Rhea-AI Summary
Berman Tabacco investigates potential securities law violations by Outset Medical Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.93%
Tags
none
-
Rhea-AI Summary
Outset Medical, Inc. announces preliminary financial results for Q3 2023 and updated financial guidance for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.93%
Tags
Rhea-AI Summary
Outset Medical to participate in fireside chat at Morgan Stanley Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.18%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
conferences

FAQ

What is the current stock price of Outset Medical (OM)?

The current stock price of Outset Medical (OM) is $1.21 as of December 20, 2024.

What is the market cap of Outset Medical (OM)?

The market cap of Outset Medical (OM) is approximately 59.2M.

What is Outset Medical, Inc.?

Outset Medical, Inc. is a medical technology company focused on innovating dialysis treatment with its Tablo dialysis machine.

What product does Outset Medical offer?

Outset Medical offers the Tablo dialysis machine, designed to simplify and reduce the cost and complexity of dialysis.

How does the Tablo dialysis system work?

Tablo features a touchscreen display with step-by-step visual and conversational instructions, making it easy to use for patients and caregivers.

In what settings can Tablo be used?

Tablo can be used in hospitals, chronic care dialysis clinics, and at home.

What is the company's main mission?

Outset Medical aims to improve the care experience and cost-efficiency for patients, families, providers, and physicians.

Who can use the Tablo machine?

Tablo is designed to be user-friendly, making it accessible for both new and experienced patients and caregivers.

What is unique about the Tablo machine?

Tablo offers a simple, user-friendly interface with step-by-step instructions, reducing the complexity of dialysis treatments.

How does Outset Medical foster innovation?

Outset Medical combines expertise from various healthcare fields to drive cross-disciplinary innovation in dialysis technology.

What recent achievements does Outset Medical have?

Outset Medical has achieved regulatory approvals and formed partnerships to expand the reach and functionalities of the Tablo machine.

How has Outset Medical performed financially?

Outset Medical has shown robust financial growth, supported by continuous innovation and a dedicated professional team.

Outset Medical, Inc.

Nasdaq:OM

OM Rankings

OM Stock Data

59.22M
51.38M
2.11%
52.2%
5.51%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
SAN JOSE